Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Marksans Pharma Ltd (MARK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
172.00 +4.85    +2.90%
26/04 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE750C01026 
S/N:  MARKSANS
  • Volume: 2,107,130
  • Bid/Ask: 171.40 / 172.00
  • Day's Range: 166.15 - 173.80
Marksans Pharma Ltd 172.00 +4.85 +2.90%

MARK Ratios

 
Assess the performance of Marksans Pharma Ltd (MARK). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Marksans Pharma Ltd's latest financial reports. Compare the performance metrics of Marksans Pharma Ltd (MARK) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 24.64 17.47
Price to Sales TTM 3.71 7.29
Price to Cash Flow MRQ - 2.12
Price to Free Cash Flow TTM 87.21 64.07
Price to Book MRQ 4.16 7.35
Price to Tangible Book MRQ 4.16 7.41
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 50.99% 64
Gross Margin 5YA 51.53% 63.15
Operating margin TTM 18.62% 16.07
Operating margin 5YA 16.11% 19.48
Pretax margin TTM 20.32% 16.6
Pretax margin 5YA 16.83% 19.8
Net Profit margin TTM 15.04% 12
Net Profit margin 5YA 12.98% 12.36
   
Revenue/Share TTM 46.42 451.88
Basic EPS ANN 6.39 63.16
Diluted EPS ANN 6.39 63.1
Book Value/Share MRQ 41.39 397.67
Tangible Book Value/Share MRQ 38.95 332.29
Cash/Share MRQ 14.58 80.43
Cash Flow/Share TTM 5.58 82.86
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 20.16% 15.82
Return on Equity 5YA 21.38% 49.57
Return on Assets TTM 0% 2.27
Return on Assets 5YA 15.1% 9.84
Return on Investment TTM 17.78% 14.59
Return on Investment 5YA 18.66% 13.05
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 17.95% -35.06
EPS(TTM) vs TTM 1 Yr. Ago TTM 32.98% 58.24
5 Year EPS Growth 5YA 48.83% 15.98
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 22.15% 10.65
Sales (TTM) vs TTM 1 Yr. Ago TTM 17.89% 222.09
5 Year Sales Growth 5YA 15.2% 12.3
5 Year Capital Spending Growth 5YA 6.61% 3.39
   
Quick Ratio MRQ 3.34 1.91
Current Ratio MRQ - 0.43
LT Debt to Equity MRQ - 6.1
Total Debt to Equity MRQ 5.92% 15.87
Efficiency    
Asset Turnover TTM - 0.07
Inventory Turnover TTM 3.89 3.41
Revenue/Employee TTM 24.69M 10.40M
Net Income/Employee TTM 3.76M 1.35M
Receivable Turnover TTM - 0.29
   
Dividend Yield ANN 0.36% 0.95
Dividend Yield 5 Year Avg. 5YA 0.36% 0.84
Dividend Growth Rate ANN - 8.43
Payout Ratio TTM - 2.57
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MARK Comments

Write your thoughts about Marksans Pharma Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Pankaj Tamrkar
Pankaj Tamrkar Jan 02, 2024 8:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
marksans 160 pe fir se aayega
Narendra Gangras
Narendra Gangras Aug 18, 2023 1:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Earnings Quality for fin yr 2022-23 is low. Accruals are about 29%. Rest financials are ok.
KOLA UMA
KOLA UMA May 22, 2022 8:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is not giving better yield either improvement in share price or dividend for the last 3 to 5 years.
KOLA UMA
KOLA UMA May 22, 2022 8:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is not giving better yield either improvement in share price or dividend for the last 3 to 5 years.
Dilip Gite
Dilip Gite May 04, 2022 2:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TP 68 upto June 2022
Dilip Gite
Dilip Gite May 04, 2022 2:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TP 68 upto June 2022
ANIL SHETTY YELINJE
ANIL SHETTY YELINJE Sep 16, 2021 11:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hold after Q2 results will touch 98 plus .......best buy at current price ..good luck anil shetty yelinje
Vipul dashrath
Vipul dashrath Sep 09, 2021 11:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wait for some time Traget is 200I had purchased 2572 share at rate of 72.50
Mitta krishna sai sagar
Mitta krishna sai sagar Sep 09, 2021 11:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
u have sold or u put on hold?
Mitta krishna sai sagar
Mitta krishna sai sagar Sep 09, 2021 11:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
u have sold or u put on hold?
mohd muzammil muzu
mohd muzammil muzu Jul 16, 2021 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
markson ph is fundamental stong stock hold tgt 150
Pradeep Vispute
Pradeep Vispute Jun 15, 2021 10:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will cross 100 this month
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email